Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Merck & Co. research leads to novel vitronectin antagonists for osteoporosis, cancer, etc.

June 8, 1998

Sodium channel modulators under evaluation at Takeda

June 8, 1998

Dopamine agonists from AHP particularly useful in the treatment of schizophrenia

June 8, 1998

Lilly patents nonclassical antifolates for cancer, arthritis and psoriasis

June 8, 1998

Bronchotherapeutic agents in development at Byk Gulden

June 8, 1998

Fujisawa compounds lower blood cholesterol, triglyceride and lipid levels

June 5, 1998

Series of dopamine receptor subtype-selective ligands developed at Pfizer

June 5, 1998

Synthelabo discloses new agents for urinary incontinence

June 5, 1998

Cryptophycins for cancer, fungal infections described in patent literature

June 5, 1998

Novel series of 5-HT1F agonists under study at Lilly

June 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...